Teva makes unsolicited $82-a-share offer for Mylan (Video) - Pittsburgh Business Times
Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats | Fierce Pharma
Mylan board rejects Teva takeover bid
Teva, Maker of Generic Drugs, Bids $40 Billion to Acquire Its Rival Mylan - The New York Times
Mylan Raises Offer for Perrigo Again and Is Rejected Again - The New York Times
$40B deal: Teva offers to buy Mylan
Mylan says merger with Teva would be bad fit | Reuters
EC nod for Mylan merger with Upjohn; Copaxone patent win
Mylan-Pfizer off-patent merger boosts Teva - Globes
Mylan rejects Teva's $40.1 billion cash and stock offer
Teva offers to buy Mylan for $40.1 billion - The Economic Times
Pfizer to spinoff, merge off-patent drugs unit with Mylan | Reuters
Mylan/Viatris and Teva at the 38th Annual J.P. Morgan Healthcare Conference - MidgardFinance.com
Teva Offers to acquire Mylan for $40 billion in cash, stock | Pharma Companies
Teva Makes $40.1 Billion Takeover Bid For Mylan | Mint
Teva bid for Mylan sparks worries of rising generic drug prices - The Economic Times
Brief Healthcare: MergerTalk: Pfizer/Mylan -Don't Overdose on the Sector, but Mylan Over Teva Pair Trade Is Still On and more | Smartkarma
Teva gets a boost as billionaire Buffett reports $358M stake | Fierce Pharma
Mylan rejects Teva's $40 bn offer as 'gross undervaluation' | The Financial Express
As Teva claims initial stake, Mylan continues to refuse takeover advances | NASDAQ:TEVA
Mylan Rejects Teva's $40 Billion Takeover Offer - The New York Times
Mylan/Viatris and Teva at the 38th Annual J.P. Morgan Healthcare Conference - MidgardFinance.com
